Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 837 | 971 | 858 | - | - | - |
| Fund Return | -16.26% | -2.92% | -14.24% | - | - | - |
| Place in category | - | - | - | - | - | - |
| % in Category | - | - | - | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Tebon Xinxing Value mix A | 10.74B | 6.68 | 48.69 | 16.70 | ||
| Tebon Xinxing Value mix C | 10.74B | 6.67 | 48.55 | 16.39 | ||
| Tebon Big Health Flxbl Alloc Fd | 141.45M | 6.45 | -8.55 | 8.75 | ||
| Tebon Fuxin Flxble Alloc A | 129.59M | 15.80 | 3.28 | 7.94 | ||
| Tebon Fuxin Flxble Alloc C | 129.59M | 15.78 | 3.02 | 7.63 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Tebon Xinxing Value mix C | 10.74B | 6.67 | 48.55 | 16.39 | ||
| Tebon Xinxing Value mix A | 10.74B | 6.68 | 48.69 | 16.70 | ||
| IGW Stable Return Flexible Fd C | 6.73B | 4.09 | 47.79 | 16.39 | ||
| IGW Stable Return Flexible Fd A | 6.73B | 4.09 | 48.19 | 16.69 | ||
| Lion Stable Return Flexible A | 2.38B | 17.38 | 20.23 | 7.46 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| O-Film Tech A | CNE100000S33 | 7.59 | 9.73 | -0.61% | |
| Northeast Phar A | CNE0000009G0 | 4.60 | 5.26 | +0.19% | |
| Hubei Jumpcan Pharm | CNE0000018X6 | 4.36 | 26.80 | -1.25% | |
| New Beiyang It A | CNE100000M62 | 4.19 | 8.02 | +2.17% | |
| Kelun Pharm A | CNE100000PW7 | 4.06 | 32.20 | +2.29% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | BUY |
| Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review